$MYGN
MYRIAD GENETICS INC

2012 Q4 Form 10-Q Financial Statement

#000119312513040306 Filed on February 06, 2013

View on sec.gov

Income Statement

Concept 2012 Q4 2011 Q4
Revenue $149.1M $122.8M
YoY Change 21.44% 22.32%
Cost Of Revenue $15.57M $12.82M
YoY Change 21.47% 6.79%
Gross Profit $133.6M $110.0M
YoY Change 21.44% 24.43%
Gross Profit Margin 89.56% 89.57%
Selling, General & Admin $59.56M $50.99M
YoY Change 16.82% 16.67%
% of Gross Profit 44.59% 46.35%
Research & Development $14.11M $10.24M
YoY Change 37.72% 67.92%
% of Gross Profit 10.56% 9.31%
Depreciation & Amortization $2.300M $2.300M
YoY Change 0.0% 35.29%
% of Gross Profit 1.72% 2.09%
Operating Expenses $73.67M $61.23M
YoY Change 20.32% 22.7%
Operating Profit $55.59M $45.47M
YoY Change 22.26% 18.09%
Interest Expense $1.400M $1.400M
YoY Change 0.0% 180.0%
% of Operating Profit 2.52% 3.08%
Other Income/Expense, Net $1.399M -$100.0K
YoY Change -1499.0% 0.0%
Pretax Income $56.99M $46.78M
YoY Change 21.81% 19.65%
Income Tax $21.95M $18.49M
% Of Pretax Income 38.52% 39.52%
Net Earnings $35.04M $28.30M
YoY Change 23.82% 16.93%
Net Earnings / Revenue 23.49% 23.04%
Basic Earnings Per Share $0.43 $0.33
Diluted Earnings Per Share $0.42 $0.33
COMMON SHARES
Basic Shares Outstanding 81.69M shares 84.50M shares
Diluted Shares Outstanding 84.24M shares 86.23M shares

Balance Sheet

Concept 2012 Q4 2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $358.6M $350.6M
YoY Change 2.28% -10.4%
Cash & Equivalents $68.42M $108.8M
Short-Term Investments $290.2M $241.8M
Other Short-Term Assets $11.70M $27.50M
YoY Change -57.45% 109.92%
Inventory $10.47M $10.30M
Prepaid Expenses $2.327M
Receivables $75.56M $43.00M
Other Receivables $1.000M $1.100M
Total Short-Term Assets $457.3M $432.4M
YoY Change 5.77% -2.79%
LONG-TERM ASSETS
Property, Plant & Equipment $27.29M $24.30M
YoY Change 12.28% 6.11%
Goodwill $56.85M
YoY Change
Intangibles $13.72M
YoY Change
Long-Term Investments $109.6M $77.60M
YoY Change 41.24% -24.73%
Other Assets $32.60M $36.10M
YoY Change -9.7% 73.56%
Total Long-Term Assets $260.4M $228.9M
YoY Change 13.77% 53.83%
TOTAL ASSETS
Total Short-Term Assets $457.3M $432.4M
Total Long-Term Assets $260.4M $228.9M
Total Assets $717.7M $661.3M
YoY Change 8.54% 11.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.58M $8.900M
YoY Change 52.53% 25.35%
Accrued Expenses $29.19M $23.70M
YoY Change 23.17% 47.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $45.49M $35.00M
YoY Change 29.97% 50.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.10M $9.400M
YoY Change 7.45% 1.08%
Total Long-Term Liabilities $10.10M $9.400M
YoY Change 7.45% 1.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $45.49M $35.00M
Total Long-Term Liabilities $10.10M $9.400M
Total Liabilities $55.63M $44.50M
YoY Change 25.0% 36.92%
SHAREHOLDERS EQUITY
Retained Earnings -$4.272M
YoY Change
Common Stock $813.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $662.1M $616.8M
YoY Change
Total Liabilities & Shareholders Equity $717.7M $661.3M
YoY Change 8.54% 11.4%

Cashflow Statement

Concept 2012 Q4 2011 Q4
OPERATING ACTIVITIES
Net Income $35.04M $28.30M
YoY Change 23.82% 16.93%
Depreciation, Depletion And Amortization $2.300M $2.300M
YoY Change 0.0% 35.29%
Cash From Operating Activities $22.10M $27.50M
YoY Change -19.64% -25.88%
INVESTING ACTIVITIES
Capital Expenditures -$4.500M -$3.900M
YoY Change 15.38% 56.0%
Acquisitions
YoY Change
Other Investing Activities -$29.50M $19.50M
YoY Change -251.28% -139.0%
Cash From Investing Activities -$34.00M $15.60M
YoY Change -317.95% -129.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.30M 3.000M
YoY Change -610.0% -107.46%
NET CHANGE
Cash From Operating Activities 22.10M 27.50M
Cash From Investing Activities -34.00M 15.60M
Cash From Financing Activities -15.30M 3.000M
Net Change In Cash -27.20M 46.10M
YoY Change -159.0% -182.76%
FREE CASH FLOW
Cash From Operating Activities $22.10M $27.50M
Capital Expenditures -$4.500M -$3.900M
Free Cash Flow $26.60M $31.40M
YoY Change -15.29% -20.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
80577812 shares
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52681000
CY2012Q2 us-gaap Goodwill
Goodwill
56850000
CY2012Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
72528000
CY2012Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
5572000
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
635660000
CY2012Q2 us-gaap Other Assets
OtherAssets
8000000
CY2012Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
113692000
CY2012Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
54728000
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
82569000 shares
CY2012Q2 us-gaap Notes Receivable Net
NotesReceivableNet
19000000
CY2012Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
254180000
CY2012Q2 us-gaap Liabilities
Liabilities
54975000
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10141000
CY2012Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10008000
CY2012Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1713000
CY2012Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2054000
CY2012Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
30648000
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12684000
CY2012Q2 us-gaap Assets
Assets
690635000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.32
CY2012Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
60441000
CY2012Q2 us-gaap Inventory Net
InventoryNet
11574000
CY2012Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
420007000
CY2012Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
690635000
CY2012Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
17800000
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2327000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86352000
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
82569000 shares
CY2012Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15722000
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-162000
CY2012Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
32772000
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
44967000
CY2012Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4600000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15233281 shares
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
826000
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q2 us-gaap Assets Current
AssetsCurrent
422492000
CY2012Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q2 us-gaap Other Receivables
OtherReceivables
2660000
CY2012Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
48297000
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24231000
CY2012Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
647680000
CY2011Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
25000000
CY2011Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.06 pure
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108848000
CY2012Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.07 pure
CY2012Q3 mygn Fair Value Option Loans Aggregate Principal Amount Outstanding
FairValueOptionLoansAggregatePrincipalAmountOutstanding
8000000
CY2012Q4 us-gaap Goodwill
Goodwill
56850000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
79594000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
8896094 shares
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
9354000
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
290210000
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
1350000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
662120000
CY2012Q4 us-gaap Other Assets
OtherAssets
8000000
CY2012Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
109636000
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
61427000
CY2012Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
47138000
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81305000 shares
CY2012Q4 us-gaap Notes Receivable Net
NotesReceivableNet
20333000
CY2012Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
290210000
CY2012Q4 us-gaap Liabilities
Liabilities
55626000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13575000
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
108226000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10138000
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
108286000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
45488000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2721000
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
290092000
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
24590000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4272000
CY2012Q4 us-gaap Assets
Assets
717746000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.35
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
19.67
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
75564000
CY2012Q4 us-gaap Inventory Net
InventoryNet
10467000
CY2012Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
440582000
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
717746000
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
18167000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68423000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81305000 shares
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13719000
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
468241000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-221000
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29192000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5300000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16181638 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
813000
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Assets Current
AssetsCurrent
457333000
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
1500000
CY2012Q4 us-gaap Other Receivables
OtherReceivables
988000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
52309000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27285000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
665800000
CY2012Q4 mygn Cash And Cash Equivalents And Available For Sale Securities Debt Maturities Estimated Fair Value
CashAndCashEquivalentsAndAvailableForSaleSecuritiesDebtMaturitiesEstimatedFairValue
468269000
CY2012Q4 mygn Accrued Value Of Loan Agreement
AccruedValueOfLoanAgreement
20333000
CY2012Q4 mygn Residual Value Of Loan Agreement
ResidualValueOfLoanAgreement
17000000
us-gaap Costs And Expenses
CostsAndExpenses
146327000
us-gaap Payments To Acquire Projects
PaymentsToAcquireProjects
750000
us-gaap Operating Income Loss
OperatingIncomeLoss
86936000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2502000
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
16569000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
799000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
53394000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
52990000
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
100000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7687000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4438000
us-gaap Share Based Compensation
ShareBasedCompensation
13271000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
5216000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10589000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
55466000
us-gaap Other Noncash Expense
OtherNoncashExpense
750000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.40 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
59354000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13103000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1856000
us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
17000000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
205000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1122000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-31274000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-205000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
56167000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86602000 shares
us-gaap Other Payments To Acquire Businesses
OtherPaymentsToAcquireBusinesses
8000000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3380000
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2612000 shares
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-203000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
88587000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18748000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16290000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
166000
us-gaap Cost Of Revenue
CostOfRevenue
24115000
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
29000
us-gaap Other Operating Income
OtherOperatingIncome
1651000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
31489000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
667000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84870000 shares
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2111000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1732000 shares
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
6364000
us-gaap Revenues
Revenues
233263000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
221579000
mygn Segment Reporting Depreciation And Amortization
SegmentReportingDepreciationAndAmortization
4438000
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-12-31
dei Entity Central Index Key
EntityCentralIndexKey
0000899923
mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
36195000
mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
19271000
dei Trading Symbol
TradingSymbol
MYGN
dei Entity Registrant Name
EntityRegistrantName
MYRIAD GENETICS INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
159858000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
11684000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8770000 shares
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
204826000
us-gaap Net Income Loss
NetIncomeLoss
53394000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
31489000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
97100000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
616000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35193000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-201000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
550000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2045000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
us-gaap Costs And Expenses
CostsAndExpenses
178409000
us-gaap Operating Income Loss
OperatingIncomeLoss
104168000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3434000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
65172000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-4000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
65113000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
23903000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4455000
us-gaap Share Based Compensation
ShareBasedCompensation
13704000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
27.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
7008000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
21.88
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
14729000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1720405 shares
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1490000
us-gaap Basis Of Accounting
BasisOfAccounting
<div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(1)</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><u>Basis of Presentation</u></font></td> </tr> </table> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The accompanying condensed consolidated financial statements have been prepared by Myriad Genetics, Inc. (the &#x201C;Company&#x201D;) in accordance with U.S. generally accepted accounting principles (&#x201C;GAAP&#x201D;) for interim financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#x201C;SEC&#x201D;). The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with GAAP. The condensed consolidated financial statements herein should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and notes thereto for the fiscal year ended June&#xA0;30, 2012, included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended June&#xA0;30, 2012. Operating results for the three and six months ended December&#xA0;31, 2012 may not necessarily be indicative of results to be expected for any other interim period or for the full year.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></p> </div>
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
79883000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.39 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
73470000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39042000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2753000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
114000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
667000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.96
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-5899000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-114000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-17929000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M6D
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84091000 shares
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
29851000
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3067000 shares
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-72000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
106807000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25507000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-52357000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
606000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
130000
us-gaap Cost Of Revenue
CostOfRevenue
29498000
us-gaap Revenues
Revenues
282577000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
267919000
us-gaap Other Operating Income
OtherOperatingIncome
2639000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
3623000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1333000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81632000 shares
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
239264000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
14658000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segment
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1107000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2459000 shares
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
7713000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
213861 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4585000 shares
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
207230000
us-gaap Net Income Loss
NetIncomeLoss
65172000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3623000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
115691000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1672000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2882623 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41635000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
506000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3580000
mygn Segment Reporting Depreciation And Amortization
SegmentReportingDepreciationAndAmortization
4455000
mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
56760000
mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
23122000
mygn Income Related To Accretion Of Note Receivable And Stated Interest Rate
IncomeRelatedToAccretionOfNoteReceivableAndStatedInterestRate
2202000
mygn Share Based Compensation Arrangement Common Shares Eligible For Purchase Related To Options Vested And Exercisable Number
ShareBasedCompensationArrangementCommonSharesEligibleForPurchaseRelatedToOptionsVestedAndExercisableNumber
8220976 shares
CY2012Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
19800000
CY2011Q3 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
200000000
CY2011Q4 us-gaap Costs And Expenses
CostsAndExpenses
77346000
CY2011Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
45465000
CY2011Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
28296000
CY2011Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
28156000
CY2011Q4 us-gaap Share Based Compensation
ShareBasedCompensation
6607000
CY2011Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2011Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.40 pure
CY2011Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
1382000
CY2011Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
64000
CY2011Q4 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-64000
CY2011Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86231000 shares
CY2011Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
928000 shares
CY2011Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-80000
CY2011Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
46783000
CY2011Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2011Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10243000
CY2011Q4 us-gaap Cost Of Revenue
CostOfRevenue
12815000
CY2011Q4 us-gaap Other Operating Income
OtherOperatingIncome
1318000
CY2011Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84498000 shares
CY2011Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1733000 shares
CY2011Q4 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
3302000
CY2011Q4 us-gaap Revenues
Revenues
122811000
CY2011Q4 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
117610000
CY2011Q4 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
5201000
CY2011Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9703000 shares
CY2011Q4 us-gaap Net Income Loss
NetIncomeLoss
28296000
CY2011Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
50986000
CY2011Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18487000
CY2011Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-60000
CY2011Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
275000
CY2011Q4 mygn Segment Reporting Depreciation And Amortization
SegmentReportingDepreciationAndAmortization
2291000
CY2011Q4 mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
11426000
CY2011Q4 mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
6858000
CY2012Q4 us-gaap Costs And Expenses
CostsAndExpenses
93554000
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
55586000
CY2012Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
35036000
CY2012Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
34686000
CY2012Q4 us-gaap Share Based Compensation
ShareBasedCompensation
7105000
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2012Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.39 pure
CY2012Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
1385000
CY2012Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
-14000
CY2012Q4 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
14000
CY2012Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84240000 shares
CY2012Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1231000 shares
CY2012Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-280000
CY2012Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
56985000
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2012Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14107000
CY2012Q4 us-gaap Cost Of Revenue
CostOfRevenue
15566000
CY2012Q4 us-gaap Other Operating Income
OtherOperatingIncome
1399000
CY2012Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81692000 shares
CY2012Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2548000 shares
CY2012Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2012Q4 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
4318000
CY2012Q4 us-gaap Revenues
Revenues
149140000
CY2012Q4 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
140651000
CY2012Q4 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
8489000
CY2012Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5605000 shares
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
35036000
CY2012Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
59563000
CY2012Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21949000
CY2012Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-70000
CY2012Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
231000
CY2012Q4 mygn Segment Reporting Depreciation And Amortization
SegmentReportingDepreciationAndAmortization
2211000
CY2012Q4 mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
24311000
CY2012Q4 mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
9372000
CY2012Q4 mygn Income Related To Accretion Of Note Receivable And Stated Interest Rate
IncomeRelatedToAccretionOfNoteReceivableAndStatedInterestRate
1104000

Files In Submission

Name View Source Status
0001193125-13-040306-index-headers.html Edgar Link pending
0001193125-13-040306-index.html Edgar Link pending
0001193125-13-040306.txt Edgar Link pending
0001193125-13-040306-xbrl.zip Edgar Link pending
d446258d10q.htm Edgar Link pending
d446258dex311.htm Edgar Link pending
d446258dex312.htm Edgar Link pending
d446258dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
mygn-20121231.xml Edgar Link completed
mygn-20121231.xsd Edgar Link pending
mygn-20121231_cal.xml Edgar Link unprocessable
mygn-20121231_def.xml Edgar Link unprocessable
mygn-20121231_lab.xml Edgar Link unprocessable
mygn-20121231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending